A detailed history of Archvest Wealth Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Archvest Wealth Advisors, Inc. holds 1,596 shares of ABT stock, worth $204,303. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,596
Previous 1,796 11.14%
Holding current value
$204,303
Previous $203,000 3.94%
% of portfolio
0.18%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025

SELL
$111.1 - $140.22 $22,220 - $28,044
-200 Reduced 11.14%
1,596 $211,000
Q3 2024

Nov 04, 2024

BUY
$100.07 - $118.13 $179,725 - $212,161
1,796 New
1,796 $204,000
Q1 2024

Apr 29, 2024

BUY
$109.52 - $120.96 $196,697 - $217,244
1,796 New
1,796 $204,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Archvest Wealth Advisors, Inc. Portfolio

Follow Archvest Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archvest Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Archvest Wealth Advisors, Inc. with notifications on news.